← Back to Search

Acceptance-Based Behavior Therapy for HIV/AIDS

N/A

Recruiting

Led By Ethan Moitra, Ph.D.

Research Sponsored by Brown University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 52 weeks

Awards & highlights

Study Summary

This trial will test a new intervention, ABBT, to see if it can help improve HIV patients' commitment to medical care.

Who is the study for?

This trial is for adults over 18 who have recently been diagnosed with HIV and are starting medical care for it. Participants must speak and read English well enough to follow the study procedures and have access to a telephone. People with cognitive impairments cannot join.Check my eligibility

What is being tested?

The trial is testing Acceptance-Based Behavior Therapy (ABBT) against an Enhanced-Treatment-as-Usual (ETAU) control condition, aiming to improve commitment to medical care among new HIV patients. It's a randomized study, meaning participants are randomly assigned to one of the two groups.See study design

What are the potential side effects?

Since ABBT is a form of therapy rather than medication, traditional side effects like those seen with drugs aren't expected. However, discussing sensitive topics during therapy could potentially cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 52 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~52 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 52 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Retention in medical care

Virologic suppression

Secondary outcome measures

Brief HIV Disclosure and Safer Sex Self-Efficacy Scales (BHD)

HIV Stigma Scale (HSS)

Self-Rating Scale Item (SRSI) - Antiretroviral Treatment adherence

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Acceptance-Based Behavior Therapy (ABBT)Experimental Treatment1 Intervention

The 2-session ABBT will be delivered in person at session 1 and by telephone at session 2.

Group II: Enhanced-Treatment-as-Usual (ETAU)Placebo Group1 Intervention

In addition to receiving treatment-as-usual at the clinic, ETAU participants will receive a 2-session program of HIV education.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor

456 Previous Clinical Trials

558,046 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,422 Total Patients Enrolled

Ethan Moitra, Ph.D.Principal InvestigatorBrown University

2 Previous Clinical Trials

250 Total Patients Enrolled

Media Library

Acceptance-Based Behavior Therapy (ABBT) Clinical Trial Eligibility Overview. Trial Name: NCT04201288 — N/A

HIV/AIDS Research Study Groups: Acceptance-Based Behavior Therapy (ABBT), Enhanced-Treatment-as-Usual (ETAU)

HIV/AIDS Clinical Trial 2023: Acceptance-Based Behavior Therapy (ABBT) Highlights & Side Effects. Trial Name: NCT04201288 — N/A

Acceptance-Based Behavior Therapy (ABBT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04201288 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are taking part in this experiment?

"Affirmative. The information provided on clinicaltrials.gov suggests that this research initiative, initially posted on December 21st 2020, is actively enrolling participants. 270 human subjects must be recruited from a single trial site."

Answered by AI

What effects is the research team hoping to achieve from this experiment?

"The primary indicator for success in this trial, assessed during the course of 52 weeks will be Viral Suppression. Secondary objectives include measuring HIV-related stigma through the HIV Stigma Scale (HSS; range: 6 - 24), patient's adherence to antiretroviral medication with the Self Rating Scale Item (SRSI; range 0 - 5) and perceived social support by way of the Multidimensional Scale of Perceived Social Support (MSPSS; range 1 - 84)."

Answered by AI

Are there any available slots for prospective participants of this research project?

"Indeed, the trial is actively recruiting participants. According to clinicaltrials.gov, this study was made available on December 21st 2020 and underwent a revision as of November 9th 2021."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients

2020. "Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04201288.

All > Aids